[en] Most pituitary adenomas are sporadic, but 3-5% can occur in a family and hereditary context. This is the case of multiple endocrine neoplasia type 1 (MEN1), Carney complex (CNC) and familial isolated pituitary adenomas (FIPA). FIPA is an infrequent condition that occurs in a family context, not associated with MEN type1 or CNC. FIPA kindred can be homogeneous (all adenomas affected in the family having the same tumor phenotype) or heterogeneous (different tumor phenotypes in the affected members). We describe a Congolese family in which two sisters and a cousin were diagnosed with a prolactinoma (homogenous FIPA) at the ages of 29, 32 and 40 years, respectively. The patients presented with macroadenomas at the time of diagnosis, non-invasive tumors and good biological response to cabergoline treatment (maximum dose of 1.5 mg/weekly). Of these two sisters, one went through a pregnancy without complications. Because no MEN1 and CNC clinical and biochemical features were detected during the 12-year follow-up, these genes were not investigated. The genetic analysis of the aryl hydrocarbon receptor interacting protein (AIP) was normal. As nearly 80% of patients with FIPA do not have a mutation in the AIP gene, future studies in these families are required to identify other affected genes involved in their physiopathology.
Disciplines :
Endocrinology, metabolism & nutrition
Author, co-author :
Vacchiano, Vanina
Seleme, Silvia
Daly, Adrian ; Université de Liège - ULiège > Département des sciences cliniques > Endocrinologie
Beckers, Albert ; Université de Liège - ULiège > Département des sciences cliniques > Endocrinologie
VALDES SOCIN, Hernan Gonzalo ; Université de Liège - ULiège > Département des sciences cliniques > Département des sciences cliniques
Language :
Spanish
Title :
Estudios clinicos y geneticos en tres miembros de una familia afectados con adenomas hipofisarios aislados con prolactinomas homogeneos.
Alternative titles :
[en] Clinical and genetic studies of a three-member familial isolated pituitary adenoma with homogeneous prolactinomas
Daly AF, Rixhon M, Adam C, Dempegioti A, Tichomirowa MA, Beckers A. High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium. J Clin Endocrinol Metab 2006; 91: 4769-75.
Beckers A, Daly AF. The clinical, pathological and genetic features of familial isolated pituitary adenomas. Eur J Endocrinol 2007; 157: 371-82.
Valdés-Socin H, Poncin J, Stevens V, Stevenaert A, Beckers A. Adénomes hypophysaires familiaux isoles non liés avec la mutation somatique NEM-1. Suivi de 27 patients. En: htpp://hdl.handle.net/2268/64787; consultado septiembre 2019.
Valdés-Socin H, Poncin J, Vambelinghen JF, et al. Familial pituitary tumours. En: Tamburrano G, Casanueva F, Baldelli R, eds. Dalla Riserca di base alla Clinica. Pubblicazioni Medici Scientifiche LILLY, 2001, p 24-28.
Daly AF, Beckers A. Familial isolated pituitary adenomas (FIPA) and mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene. Endocrinol Metab Clin North Am 2014; 4: 19-25.
Beckers A, Aaltonen LA, Daly AF, Karhu A. Familial isolated pituitary adenomas (FIPA) and the pituitary adenoma predisposition due to mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene. Endocr Rev 2013; 34: 239-77.
Daly AF, Vanbellinghen JF, Khoo SK, et al. Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas: analysis in 73 families. J Clin Endocrinol Metab 2007; 92: 1891-6.
Rostomyan L, Daly AF, Petrossians P, et al. Clinical and genetic characterization of pituitary gigantism: an international collaborative study in 208 patients. Endocr Relat Cancer 2015; 22: 745-57.
Trivellin G, Daly AF, Faucz FR, et al. Gigantism and acromegaly due to Xq26 microduplications and GPR101 mutation. N Engl J Med 2014; 371: 2363-74.
Beckers A, Lodish MB, Trivellin G, et al. X-linked acrogigantism syndrome: clinical profile and therapeutic responses. Endocr Relat Cancer 2015; 22: 353-67.
Daly A, Tichomirowa MA, Petrossians P, et al. Clinical characteristics and therapeutic responses in patients with germ-line AIP mutations and pituitary adenomas: an international collaborative study. J Clin Endocrinol Metab 2010; 95: E373-83.
Vilar L, Abucham J, Albuquerque JL, et al. Controversial issues in the management of hyperprolactinemia and prolactinomas - An overview by the Neuroendocrinology Department of the Brazilian Society of Endocrinology and Metabolism. Arch Endocrinol Metab 2018; 62: 236-63.
Valdes-Socin H, Potorac I, Janin N, Bourguignon JP, Beckers A. Macroprolactinome pédiatrique sporadique associé à une mutation germinale AIP R304Q: Ré- mission quatre ans après l’interruption d’un traitement par Cabergoline. En: http://hdl.handle.net/2268/174088; consultado septiembre 2019.
Leontiou CA, Gueorguiev M, van der Spuy J, et al. The role of the aryl hydrocarbon receptor-interacting protein gene in familial and sporadic pituitary adenomas. J Clin Endocrinol Metab 2008; 93: 2390-401.
Vroonen L, Daly AF, Beckers A. Epidemiology and management challenges in prolactinomas. Neuroendocrinology 2019; 109: 20-7.